Annual CFO:
-$194.41M-$1.10M(-0.57%)Summary
- As of today, INBX annual cash from operations is -$194.41 million, with the most recent change of -$1.10 million (-0.57%) on December 31, 2024.
- During the last 3 years, INBX annual cash from operations has fallen by -$114.09 million (-142.03%).
- INBX annual cash from operations is now -936.74% below its all-time high of -$18.75 million, reached on December 31, 2017.
Performance
INBX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$33.82M-$3.87M(-12.92%)Summary
- As of today, INBX quarterly cash from operations is -$33.82 million, with the most recent change of -$3.87 million (-12.92%) on September 30, 2025.
- Over the past year, INBX quarterly cash from operations has dropped by -$3.54 million (-11.70%).
- INBX quarterly cash from operations is now -4275.68% below its all-time high of -$773.00 thousand, reached on September 30, 2019.
Performance
INBX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$143.39M-$3.54M(-2.53%)Summary
- As of today, INBX TTM cash from operations is -$143.39 million, with the most recent change of -$3.54 million (-2.53%) on September 30, 2025.
- Over the past year, INBX TTM cash from operations has increased by +$7.30 million (+4.84%).
- INBX TTM cash from operations is now -6682.97% below its all-time high of -$2.11 million, reached on March 31, 2018.
Performance
INBX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
INBX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -0.6% | -11.7% | +4.8% |
| 3Y3 Years | -142.0% | -9.7% | -33.6% |
| 5Y5 Years | -506.0% | -143.7% | -222.1% |
INBX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -142.0% | at low | -12.9% | +46.4% | -36.1% | +26.2% |
| 5Y | 5-Year | -506.0% | at low | -147.3% | +46.4% | -222.1% | +26.2% |
| All-Time | All-Time | -936.7% | at low | -4275.7% | +46.4% | -6683.0% | +26.2% |
INBX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$33.82M(-12.9%) | -$143.39M(-2.5%) |
| Jun 2025 | - | -$29.95M(+16.6%) | -$139.85M(+16.4%) |
| Mar 2025 | - | -$35.90M(+17.9%) | -$167.25M(+14.0%) |
| Dec 2024 | -$194.41M(-0.6%) | -$43.72M(-44.4%) | -$194.41M(-29.0%) |
| Sep 2024 | - | -$30.28M(+47.2%) | -$150.69M(-25.1%) |
| Jun 2024 | - | -$57.36M(+9.0%) | -$120.41M(-14.3%) |
| Mar 2024 | - | -$63.05M(-49.1%) | -$105.35M(+26.7%) |
| Dec 2023 | -$193.31M(-112.9%) | - | - |
| Jun 2023 | - | -$42.30M(-5.9%) | -$143.68M(-12.0%) |
| Mar 2023 | - | -$39.94M(-30.5%) | -$128.30M(-11.3%) |
| Dec 2022 | -$90.81M(-13.1%) | -$30.60M(+0.8%) | -$115.30M(-7.4%) |
| Sep 2022 | - | -$30.84M(-14.5%) | -$107.32M(-19.0%) |
| Jun 2022 | - | -$26.92M(+0.1%) | -$90.16M(-5.3%) |
| Mar 2022 | - | -$26.94M(-19.1%) | -$85.62M(-6.6%) |
| Dec 2021 | -$80.32M | -$22.62M(-65.4%) | -$80.32M(-9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$13.68M(+38.9%) | -$73.09M(+0.3%) |
| Jun 2021 | - | -$22.38M(-3.4%) | -$73.30M(-17.8%) |
| Mar 2021 | - | -$21.65M(-40.7%) | -$62.23M(-29.7%) |
| Dec 2020 | -$47.97M(-49.5%) | -$15.39M(-10.9%) | -$47.97M(-7.7%) |
| Sep 2020 | - | -$13.88M(-22.8%) | -$44.52M(-41.7%) |
| Jun 2020 | - | -$11.31M(-53.1%) | -$31.41M(+7.3%) |
| Mar 2020 | - | -$7.39M(+38.1%) | -$33.89M(-5.6%) |
| Dec 2019 | -$32.08M(-38.9%) | -$11.94M(-1444.9%) | -$32.08M(-59.3%) |
| Sep 2019 | - | -$773.00K(+94.4%) | -$20.14M(-4.0%) |
| Jun 2019 | - | -$13.79M(-147.2%) | -$19.36M(-4.2%) |
| Mar 2019 | - | -$5.58M(+57.1%) | -$18.58M(-22.9%) |
| Dec 2018 | -$23.09M(-23.1%) | - | - |
| Jun 2018 | - | -$13.01M(-515.3%) | -$15.12M(-615.3%) |
| Mar 2018 | - | -$2.11M | -$2.11M |
| Dec 2017 | -$18.75M | - | - |
FAQ
- What is Inhibrx Biosciences, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. annual cash from operations year-on-year change?
- What is Inhibrx Biosciences, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. quarterly cash from operations year-on-year change?
- What is Inhibrx Biosciences, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. TTM cash from operations year-on-year change?
What is Inhibrx Biosciences, Inc. annual cash from operations?
The current annual cash from operations of INBX is -$194.41M
What is the all-time high annual cash from operations for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high annual cash from operations is -$18.75M
What is Inhibrx Biosciences, Inc. annual cash from operations year-on-year change?
Over the past year, INBX annual cash from operations has changed by -$1.10M (-0.57%)
What is Inhibrx Biosciences, Inc. quarterly cash from operations?
The current quarterly cash from operations of INBX is -$33.82M
What is the all-time high quarterly cash from operations for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high quarterly cash from operations is -$773.00K
What is Inhibrx Biosciences, Inc. quarterly cash from operations year-on-year change?
Over the past year, INBX quarterly cash from operations has changed by -$3.54M (-11.70%)
What is Inhibrx Biosciences, Inc. TTM cash from operations?
The current TTM cash from operations of INBX is -$143.39M
What is the all-time high TTM cash from operations for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high TTM cash from operations is -$2.11M
What is Inhibrx Biosciences, Inc. TTM cash from operations year-on-year change?
Over the past year, INBX TTM cash from operations has changed by +$7.30M (+4.84%)